$7.81
arrow_drop_up4.69%Key Stats | |
---|---|
Open | $7.60 |
Prev. Close | $7.46 |
EPS | -1.32 |
Dividend | Non-Dividend |
Next Earnings Date | - |
Dividend Yield % | - |
PE Ratio | - |
LOW | HIGH | |
---|---|---|
Day Range | 7.03 | 7.99 |
52 Week Range | 3.26 | 10.03 |
Ratios | |
---|---|
Revenue | - |
EBITDA Margin % | - |
EPS | -1.32 |
Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.
Period: Next 12 Months
•Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.
Can These 2 Biotechs Beat Eli Lilly and Novo Nordisk in Weight-Loss Drugs? - The Motley Fool
Terns Pharmaceuticals Highlights New Preclinical Data Supporting TERN-501 in Combination with a GLP-1R Agonist for Obesity at the ADA’s 84th Annual Scientific Sessions and Upcoming Conference Participation
Terns (TERN) Gains 13.6% YTD: Will the Momentum Continue?
Wall Street Analysts Believe Terns Pharmaceuticals (TERN) Could Rally 136.44%: Here's is How to Trade
Terns Pharmaceuticals Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(C)(4)
Terns Pharmaceuticals to Participate in Upcoming June Investor Conferences